LTIP176A - Per odą patenkanti kompozicija ir jos gavimo būdas - Google Patents

Per odą patenkanti kompozicija ir jos gavimo būdas

Info

Publication number
LTIP176A
LTIP176A LTIP176A LTIP176A LTIP176A LT IP176 A LTIP176 A LT IP176A LT IP176 A LTIP176 A LT IP176A LT IP176 A LTIP176 A LT IP176A LT IP176 A LTIP176 A LT IP176A
Authority
LT
Lithuania
Prior art keywords
transdermal composition
propyl
methyl
polymer
polyoxyethylene
Prior art date
Application number
LTIP176A
Other languages
English (en)
Inventor
Z. Anna SZABO
Gabriella Szabo
Antal Toth
Tamas Szuts
Kalman Magyar
Jozsef Lengyel
Janos Pinter
Anna Szekely
Andras Szego
Katalin Marmarosi
Original Assignee
Chinoin Gyogyszer-Es Vegyeszeti Termekek Gyara Rt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chinoin Gyogyszer-Es Vegyeszeti Termekek Gyara Rt filed Critical Chinoin Gyogyszer-Es Vegyeszeti Termekek Gyara Rt
Publication of LTIP176A publication Critical patent/LTIP176A/lt
Publication of LT3044B publication Critical patent/LT3044B/lt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Liposomes
    • A61K9/1274Non-vesicle bilayer structures, e.g. liquid crystals, tubules, cubic phases, cochleates; Sponge phases
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Išradimas skirtas bevandenei per odą patenkančiai kompozicijai, kuri būdama nuo 20 iki 100 liotropinių skystųjų kristalų būsenoje, yra sudaryta iš šių ingredientų tokiu santykiu, svorio %:@(5-15)- optiškai aktyvaus ar receminio N-metil-N-(fenil-2-propil)-2-propilamino, arba@N-metil-N-(1-(4-fluorfenil)-2-propil)-2-prpopilamino, arba jų druskų tinkamų terapiniam gydymui,@(40-70) - skysto polioksietileno,@(10-20) - kieto polioksietileno,@(2-30) - nejoninio paviršiaus aktyvaus reagento,@(2-20) - propileno glikolio, jeigu pageidaujama,@(0,5-2) - polimero, kurio spiralinę struktūrą (polimero pralaidumą) charakterizuojantis koeficentas a yra 0,6, ir, jei pageidaujama, papildoma iki 100 kitais, emulsiją sudarančiais, pagalbiniais reagentais.
LTIP176A 1991-04-15 1992-08-28 Transdermal composition and process for the preparation thereof LT3044B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU911229A HU209605B (en) 1991-04-15 1991-04-15 Process for production of wather-free transdermal preparation

Publications (2)

Publication Number Publication Date
LTIP176A true LTIP176A (lt) 1994-03-25
LT3044B LT3044B (en) 1994-09-25

Family

ID=10953442

Family Applications (1)

Application Number Title Priority Date Filing Date
LTIP176A LT3044B (en) 1991-04-15 1992-08-28 Transdermal composition and process for the preparation thereof

Country Status (35)

Country Link
US (1) US5380761A (lt)
EP (1) EP0509761B1 (lt)
JP (1) JP2547151B2 (lt)
KR (1) KR950008766B1 (lt)
AT (1) ATE142486T1 (lt)
AU (1) AU648886B2 (lt)
BG (1) BG61637B1 (lt)
CA (1) CA2065134A1 (lt)
CZ (1) CZ281261B6 (lt)
DE (1) DE69213536T2 (lt)
DK (1) DK0509761T3 (lt)
EC (1) ECSP920873A (lt)
EE (1) EE03038B1 (lt)
ES (1) ES2092031T3 (lt)
FI (1) FI101677B (lt)
GR (1) GR3021505T3 (lt)
HK (1) HK1003977A1 (lt)
HR (1) HRP920570A2 (lt)
HU (2) HU209605B (lt)
IE (1) IE921019A1 (lt)
IL (1) IL101487A (lt)
LT (1) LT3044B (lt)
LV (1) LV10044B (lt)
MX (1) MX9201732A (lt)
NO (1) NO303903B1 (lt)
NZ (1) NZ242335A (lt)
PH (1) PH29992A (lt)
PL (1) PL173234B1 (lt)
RO (1) RO109603B1 (lt)
RU (1) RU2088617C1 (lt)
SK (1) SK278666B6 (lt)
TW (1) TW198690B (lt)
UA (1) UA26892C2 (lt)
YU (1) YU48552B (lt)
ZA (1) ZA922355B (lt)

Families Citing this family (101)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6313176B1 (en) 1989-10-17 2001-11-06 Everett J. Ellinwood, Jr. Dosing method of administering deprenyl via intraoral administration or inhalation administration
HUT63579A (en) * 1991-12-20 1993-09-28 Chinoin Gyogyszer Es Vegyeszet Process for producing double-phase pharmaceutical compositions suitable for treating diseases occurring during neurodegenerative processes
AU679937B2 (en) * 1992-11-18 1997-07-17 Johnson & Johnson Consumer Products, Inc. Extrudable compositions for topical or transdermal drug delivery
US5817336A (en) * 1993-04-02 1998-10-06 Orion-Yhtyma Oy Composition containing selegiline
US6348208B1 (en) * 1995-01-13 2002-02-19 Somerset Pharmaceuticals, Inc. Methods and pharmaceutical compositions employing desmethylselegiline
US6319954B1 (en) 1995-01-13 2001-11-20 Somerset Pharmaceuticals, Inc. S-(+)-desmethylselegiline and its use in the therapeutic methods and pharmaceutical compositions
US6033682A (en) 1995-01-13 2000-03-07 Somerset Pharmaceuticals, Inc. S(+) desmethylselegiline and its use in therapeutic methods and pharmaceutical compositions
US6299901B1 (en) 1995-01-13 2001-10-09 Somerset Pharmaceuticals, Inc. Methods and pharmaceutical compositions employing desmethylselegiline
US6316022B1 (en) 1995-06-07 2001-11-13 Noven Pharmaceuticals, Inc. Transdermal compositions containing low molecular weight drugs which are liquid at room temperatures
NZ309980A (en) 1995-06-07 2001-06-29 Noven Pharma Transdermal composition containing a blend of one or more polymers, one or more drugs that has a low molecular weight and is liquid at room temperature
HUP9601442A3 (en) * 1995-07-25 1999-03-29 Panacea Biotec Ltd Nes antinflammatory and analgetic pharmaceutical compositions, containing nimesulid for transdermal use, and process for producing them
US6262111B1 (en) 1997-05-21 2001-07-17 Sloan-Kettering Institute For Cancer Research Method for increasing the concentration of ascorbic acid in brain tissues of a subject
WO1998052560A1 (en) 1997-05-21 1998-11-26 Sloan-Kettering Institute For Cancer Research Method for increasing the concentration of ascorbic acid in brain tissues of a subject
US7150881B2 (en) 1997-06-26 2006-12-19 Mylan Technologies, Inc. Adhesive mixture for transdermal delivery of highly plasticizing drugs
DE19743323C2 (de) * 1997-09-30 2000-05-25 Iip Inst Fuer Ind Pharmazie Fo Feste Arzneimittelzusammensetzung auf der Grundlage von Selegilin
BR9908713A (pt) 1998-03-16 2000-11-21 Somerset Pharmaceuticals Inc Uso de selegilina ou desmetil-selegilina para tratamento de feridas, queimaduras e danos dermatológicos
DE19814257A1 (de) 1998-03-31 1999-10-07 Asta Medica Ag Brauseformulierungen
US6316469B1 (en) 2000-03-01 2001-11-13 Duke University Use of selective serotonin reuptake inhibitors for treatment of chest pain of non-cardiac origin and gastro-esophageal reflux disease
US8512718B2 (en) 2000-07-03 2013-08-20 Foamix Ltd. Pharmaceutical composition for topical application
ATE427745T1 (de) 2001-11-05 2009-04-15 Krele Pharmaceuticals Llc Zusammensetzungen und verfahren zur erhíhung der compliance mit therapien unter verwendung von aldehyddehydrogenase-hemmern und zur behandlung von alkoholsmus
US8435942B2 (en) * 2002-05-31 2013-05-07 Transdermal Biotechnology, Inc. Methods for formulating stabilized insulin compositions
US20040018237A1 (en) * 2002-05-31 2004-01-29 Perricone Nicholas V. Topical drug delivery using phosphatidylcholine
IL152486A0 (en) 2002-10-25 2003-05-29 Meir Eini Alcohol-free cosmetic and pharmaceutical foam carrier
US20050205086A1 (en) * 2002-10-25 2005-09-22 Foamix Ltd. Retinoid immunomodulating kit and composition and uses thereof
EP1556009B2 (en) * 2002-10-25 2021-07-21 Foamix Pharmaceuticals Ltd. Cosmetic and pharmaceutical foam
US7704518B2 (en) * 2003-08-04 2010-04-27 Foamix, Ltd. Foamable vehicle and pharmaceutical compositions thereof
US20080206161A1 (en) * 2002-10-25 2008-08-28 Dov Tamarkin Quiescent foamable compositions, steroids, kits and uses thereof
US9668972B2 (en) 2002-10-25 2017-06-06 Foamix Pharmaceuticals Ltd. Nonsteroidal immunomodulating kit and composition and uses thereof
US7820145B2 (en) * 2003-08-04 2010-10-26 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
US20050186142A1 (en) * 2002-10-25 2005-08-25 Foamix Ltd. Kit and composition of imidazole with enhanced bioavailability
US8900554B2 (en) 2002-10-25 2014-12-02 Foamix Pharmaceuticals Ltd. Foamable composition and uses thereof
US20060193789A1 (en) * 2002-10-25 2006-08-31 Foamix Ltd. Film forming foamable composition
US20080138296A1 (en) 2002-10-25 2008-06-12 Foamix Ltd. Foam prepared from nanoemulsions and uses
US10117812B2 (en) * 2002-10-25 2018-11-06 Foamix Pharmaceuticals Ltd. Foamable composition combining a polar solvent and a hydrophobic carrier
US9211259B2 (en) 2002-11-29 2015-12-15 Foamix Pharmaceuticals Ltd. Antibiotic kit and composition and uses thereof
US20070292355A1 (en) * 2002-10-25 2007-12-20 Foamix Ltd. Anti-infection augmentation foamable compositions and kit and uses thereof
US8119150B2 (en) 2002-10-25 2012-02-21 Foamix Ltd. Non-flammable insecticide composition and uses thereof
US9265725B2 (en) 2002-10-25 2016-02-23 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US20080317679A1 (en) * 2002-10-25 2008-12-25 Foamix Ltd. Foamable compositions and kits comprising one or more of a channel agent, a cholinergic agent, a nitric oxide donor, and related agents and their uses
US20050271596A1 (en) * 2002-10-25 2005-12-08 Foamix Ltd. Vasoactive kit and composition and uses thereof
US20060018937A1 (en) * 2002-10-25 2006-01-26 Foamix Ltd. Steroid kit and foamable composition and uses thereof
US8119109B2 (en) * 2002-10-25 2012-02-21 Foamix Ltd. Foamable compositions, kits and methods for hyperhidrosis
US8486376B2 (en) * 2002-10-25 2013-07-16 Foamix Ltd. Moisturizing foam containing lanolin
US20070292359A1 (en) * 2002-10-25 2007-12-20 Foamix Ltd. Polypropylene glycol foamable vehicle and pharmaceutical compositions thereof
US7700076B2 (en) 2002-10-25 2010-04-20 Foamix, Ltd. Penetrating pharmaceutical foam
US7575739B2 (en) 2003-04-28 2009-08-18 Foamix Ltd. Foamable iodine composition
US8486374B2 (en) * 2003-08-04 2013-07-16 Foamix Ltd. Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses
US8795693B2 (en) 2003-08-04 2014-08-05 Foamix Ltd. Compositions with modulating agents
HUP0303313A2 (hu) * 2003-10-09 2005-07-28 Richter Gedeon Vegyészeti Gyár Rt. Transzdermális gyógyszerkészítmények
KR20080010443A (ko) * 2005-04-28 2008-01-30 도쿠리쓰교세이호징 가가쿠 기주쓰 신코 기코 피부 재생 촉진제
CA2610662A1 (en) * 2005-05-09 2007-05-18 Foamix Ltd. Foamable vehicle and pharmaceutical compositions thereof
US20080152596A1 (en) * 2005-07-19 2008-06-26 Foamix Ltd. Polypropylene glycol foamable vehicle and pharmaceutical compositions thereof
MX2009002536A (es) * 2006-09-08 2009-04-14 Foamix Ltd Composicion espumable coloreada o coloreable y espuma.
US20080260655A1 (en) * 2006-11-14 2008-10-23 Dov Tamarkin Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
WO2009007785A2 (en) * 2006-11-14 2009-01-15 Foamix Ltd. Stable non-alcoholic foamable pharmaceutical emulsion compositions with an unctuous emollient and their uses
DE102007014286A1 (de) * 2007-03-19 2008-09-25 Universität Tübingen Fluorsubstituierte Amphetamine und Amphetaminderivate und deren Verwendung
US8636982B2 (en) 2007-08-07 2014-01-28 Foamix Ltd. Wax foamable vehicle and pharmaceutical compositions thereof
US20090130029A1 (en) * 2007-11-21 2009-05-21 Foamix Ltd. Glycerol ethers vehicle and pharmaceutical compositions thereof
US9439857B2 (en) 2007-11-30 2016-09-13 Foamix Pharmaceuticals Ltd. Foam containing benzoyl peroxide
WO2010041141A2 (en) 2008-10-07 2010-04-15 Foamix Ltd. Oil-based foamable carriers and formulations
WO2009090495A2 (en) 2007-12-07 2009-07-23 Foamix Ltd. Oil and liquid silicone foamable carriers and formulations
EP2242476A2 (en) * 2008-01-14 2010-10-27 Foamix Ltd. Poloxamer foamable pharmaceutical compositions with active agents and/or therapeutic cells and uses
US20120087872A1 (en) 2009-04-28 2012-04-12 Foamix Ltd. Foamable Vehicles and Pharmaceutical Compositions Comprising Aprotic Polar Solvents and Uses Thereof
WO2011013008A2 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses
WO2011013009A2 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses
US10029013B2 (en) 2009-10-02 2018-07-24 Foamix Pharmaceuticals Ltd. Surfactant-free, water-free formable composition and breakable foams and their uses
US9849142B2 (en) 2009-10-02 2017-12-26 Foamix Pharmaceuticals Ltd. Methods for accelerated return of skin integrity and for the treatment of impetigo
JP5619438B2 (ja) * 2010-03-12 2014-11-05 株式会社フジモト・コーポレーション セレギリン含有貼付製剤
CN103547258B (zh) 2011-03-17 2017-10-20 特兰斯德梅尔生物工艺股份有限公司 局部一氧化氮系统及其使用方法
US8871255B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Treatment of skin and soft tissue infection with nitric oxide
US8871256B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Methods and systems for treatment of inflammatory diseases with nitric oxide
US8871254B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Systems and methods for treatment of acne vulgaris and other conditions with a topical nitric oxide delivery system
US8871262B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Compositions and methods for treatment of osteoporosis and other indications
US8871257B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Prevention and treatment of cardiovascular diseases using systems and methods for transdermal nitric oxide delivery
US8871261B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Cancer treatments and compositions for use thereof
US8871259B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Techniques and systems for treatment of neuropathic pain and other indications
US8871260B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Methods and compositions for muscular and neuromuscular diseases
US8871258B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Treatment and prevention of learning and memory disorders
US20140271938A1 (en) 2013-03-13 2014-09-18 Transdermal Biotechnology, Inc. Systems and methods for delivery of peptides
US9393264B2 (en) 2013-03-13 2016-07-19 Transdermal Biotechnology, Inc. Immune modulation using peptides and other compositions
US9314417B2 (en) 2013-03-13 2016-04-19 Transdermal Biotechnology, Inc. Treatment of skin, including aging skin, to improve appearance
US9314423B2 (en) 2013-03-13 2016-04-19 Transdermal Biotechnology, Inc. Hair treatment systems and methods using peptides and other compositions
US9724419B2 (en) 2013-03-13 2017-08-08 Transdermal Biotechnology, Inc. Peptide systems and methods for metabolic conditions
US9295637B2 (en) 2013-03-13 2016-03-29 Transdermal Biotechnology, Inc. Compositions and methods for affecting mood states
US9295647B2 (en) 2013-03-13 2016-03-29 Transdermal Biotechnology, Inc. Systems and methods for delivery of peptides
US9849160B2 (en) 2013-03-13 2017-12-26 Transdermal Biotechnology, Inc. Methods and systems for treating or preventing cancer
US20140271937A1 (en) 2013-03-13 2014-09-18 Transdermal Biotechnology, Inc. Brain and neural treatments comprising peptides and other compositions
US9241899B2 (en) 2013-03-13 2016-01-26 Transdermal Biotechnology, Inc. Topical systems and methods for treating sexual dysfunction
US9687520B2 (en) 2013-03-13 2017-06-27 Transdermal Biotechnology, Inc. Memory or learning improvement using peptide and other compositions
US9295636B2 (en) 2013-03-13 2016-03-29 Transdermal Biotechnology, Inc. Wound healing using topical systems and methods
US9393265B2 (en) 2013-03-13 2016-07-19 Transdermal Biotechnology, Inc. Wound healing using topical systems and methods
US9320758B2 (en) 2013-03-13 2016-04-26 Transdermal Biotechnology, Inc. Brain and neural treatments comprising peptides and other compositions
US9387159B2 (en) 2013-03-13 2016-07-12 Transdermal Biotechnology, Inc. Treatment of skin, including aging skin, to improve appearance
US9314433B2 (en) 2013-03-13 2016-04-19 Transdermal Biotechnology, Inc. Methods and systems for treating or preventing cancer
US20140271731A1 (en) 2013-03-13 2014-09-18 Transdermal Biotechnology, Inc. Cardiovascular disease treatment and prevention
US9339457B2 (en) 2013-03-13 2016-05-17 Transdermal Biotechnology, Inc. Cardiovascular disease treatment and prevention
US9314422B2 (en) 2013-03-13 2016-04-19 Transdermal Biotechnology, Inc. Peptide systems and methods for metabolic conditions
US9320706B2 (en) 2013-03-13 2016-04-26 Transdermal Biotechnology, Inc. Immune modulation using peptides and other compositions
US9750787B2 (en) 2013-03-13 2017-09-05 Transdermal Biotechnology, Inc. Memory or learning improvement using peptide and other compositions
ES2880618T3 (es) 2015-03-02 2021-11-25 Medlab Clinical U S Inc Sistemas de suministro transmucosa y transdérmico
MX2020012139A (es) 2016-09-08 2021-01-29 Vyne Pharmaceuticals Inc Composiciones y metodos para tratar rosacea y acne.

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US468218A (en) 1892-02-02 Door-securer
HU187775B (en) * 1982-07-14 1986-02-28 Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Rt,Hu New process for producing propargile-amines of pharmaceutical activity
US4868218A (en) * 1987-08-18 1989-09-19 Buyske Donald A Method of treating depression
US4861800A (en) 1987-08-18 1989-08-29 Buyske Donald A Method for administering the drug deprenyl so as to minimize the danger of side effects
IL88099A (en) * 1987-11-06 1992-02-16 Chinoin Gyogyszer Es Vegyeszet Lyotropic liquid crystalline compositions
GB8807504D0 (en) * 1988-03-29 1988-05-05 Sandoz Ltd Improvements in/relating to organic compounds
CA1313982C (en) 1988-07-29 1993-03-02 Gary Karlin Michelson Spinal retractor
US5053227A (en) * 1989-03-22 1991-10-01 Cygnus Therapeutic Systems Skin permeation enhancer compositions, and methods and transdermal systems associated therewith

Also Published As

Publication number Publication date
YU48552B (sh) 1998-11-05
ECSP920873A (es) 1994-02-02
DK0509761T3 (lt) 1997-02-17
ZA922355B (en) 1992-12-30
NO921481D0 (no) 1992-04-14
HUT63560A (en) 1993-09-28
TW198690B (lt) 1993-01-21
PH29992A (en) 1996-10-29
NO921481L (no) 1992-10-16
KR950008766B1 (ko) 1995-08-08
YU38492A (sh) 1995-03-27
BG61637B1 (bg) 1998-02-27
FI101677B1 (fi) 1998-08-14
ES2092031T3 (es) 1996-11-16
EP0509761A1 (en) 1992-10-21
MX9201732A (es) 1992-10-01
CA2065134A1 (en) 1992-10-16
US5380761A (en) 1995-01-10
LV10044B (en) 1995-02-20
DE69213536D1 (de) 1996-10-17
CZ281261B6 (cs) 1996-07-17
AU1484992A (en) 1992-10-22
RU2088617C1 (ru) 1997-08-27
ATE142486T1 (de) 1996-09-15
HU911229D0 (en) 1991-10-28
FI101677B (fi) 1998-08-14
FI921690A0 (fi) 1992-04-15
LT3044B (en) 1994-09-25
CS111092A3 (en) 1992-11-18
DE69213536T2 (de) 1997-03-20
IE921019A1 (en) 1992-10-21
IL101487A0 (en) 1992-12-30
PL294240A1 (en) 1993-09-20
JP2547151B2 (ja) 1996-10-23
PL173234B1 (pl) 1998-02-27
HK1003977A1 (en) 1998-11-13
HU211544A9 (en) 1995-12-28
UA26892C2 (uk) 1999-12-29
KR920019341A (ko) 1992-11-19
HU209605B (en) 1994-09-28
NZ242335A (en) 1994-06-27
AU648886B2 (en) 1994-05-05
BG96232A (bg) 1993-12-24
FI921690A (fi) 1992-10-16
HRP920570A2 (en) 1994-08-31
EE03038B1 (et) 1997-10-15
EP0509761B1 (en) 1996-09-11
JPH06128152A (ja) 1994-05-10
LV10044A (lv) 1994-05-10
SK278666B6 (en) 1997-12-10
GR3021505T3 (en) 1997-01-31
NO303903B1 (no) 1998-09-21
IL101487A (en) 1996-01-19
RO109603B1 (ro) 1995-04-28

Similar Documents

Publication Publication Date Title
LTIP176A (lt) Per odą patenkanti kompozicija ir jos gavimo būdas
ES2569949T3 (es) Formulaciones farmacéuticas que comprenden un péptido complejado con una dicetopiperazina
CA1209473A (en) Stable interferon b-composition and a method of stabilizing interferon b
DK0789559T4 (da) Farmaceutisk præparat indeholdende en smeltelig bærer og en fremgangsmåde til fremstilling deraf
KR870003786A (ko) 1-시클로프로필-6-플루오로-1,4-디히드로-4-옥소-7-(1-피페라지닐)-퀴놀린-3-카르복실산의 침출액
AU7880991A (en) A pharmaceutical preparation containing n-glycofurols and n-ethylene glycols
HU9802889D0 (en) Percutaneous absorption type preparation
EP0221041A3 (en) Benzimidazole derivatives, process for their preparation and their pharmaceutical use
KR950700758A (ko) 비-이온성 계면활성제 소포를 함유하는 백신(Vaccines containing non ionic surfactant vesicles)
UA40633C2 (uk) Фармацевтичний емульсійний склад, спосіб його одержання і спосіб зниження в короткий термін тиску крові
JPS6321648B2 (lt)
ATE50260T1 (de) Purinderivate, verfahren zu ihrer herstellung und pharmazeutische zubereitung.
EP0173664A3 (en) Biologically active benzimidazole compounds and process for their preparation
EP0727996A1 (en) Fenbendazole formulations
KR910005886A (ko) 안정화 백혈구 인터페론
EP0377114B1 (en) Method for preparing pertussis toxin toxoid
JP2618256B2 (ja) 消炎鎮痛外用剤
US4666926A (en) Transdermal formulations
EP0397211A2 (en) Percutaneous administration of 3'-azide-3'-deoxythymidine
US4978533A (en) Liquid nifidipine composition
JP3262592B2 (ja) 〔Asu1.7〕カルシトニン類の水溶液注射剤の安定化法
JPH07179359A (ja) 安定なエルカトニン製剤
EP0056681A2 (en) Levonantradol and N-methyllevonantradol formulations
JPH05310508A (ja) 皮膚外用剤組成物
TW223065B (lt)

Legal Events

Date Code Title Description
MM9A Lapsed patents

Effective date: 20000828